CRP and cancer: Similarly, low plasma PLP levels predispose to a higher risk of venous thrombosis(53), myocardial infarction(54), diabetes mellitus(55), COVID-19 infection(56), oxidative stress(38), increasing risk of cancer in diabetic patients(57,58), immune system disruption and CRP level elevations(39) that suggests increased risk of inflammation conditions(58).